z-logo
Premium
Acetylcholine sensitivity of biphasic Ca 2+ mobilization induced by nicotinic receptor activation at the mouse skeletal muscle endplate
Author(s) -
Dezaki Katsuya,
Kimura Ikuko
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0701725
Subject(s) - acetylcholine , nicotinic agonist , chemistry , acetylcholine receptor , endocrinology , muscarinic acetylcholine receptor , medicine , skeletal muscle , neuromuscular junction , biophysics , postsynaptic potential , agonist , nicotinic antagonist , receptor , biology , biochemistry , neuroscience
Acetylcholine (ACh) was locally applied onto the endplate region in a mouse phrenic nerve‐diaphragm muscle preparation to measure intracellular free calcium ([Ca 2+ ] i ) entry through nicotinic ACh receptors (AChRs) by use of Ca 2+ ‐aequorin luminescence. ACh (0.1–3 m m , 20 μl) elicited biphasic elevation of [Ca 2+ ] i (fast and slow Ca 2+ mobilization) in muscle cells. The peak amplitude of the slow Ca 2+ mobilization (not accompanied by twitch tension) was concentration‐dependently increased by ACh, whereas that of the fast component (accompanied by twitch tension) reached a maximum response at a lower concentration (0.1 m m ) of applied ACh. A pulse of nicotinic agonists, (−)‐nicotine (10 m m ) and 1,1‐dimethyl‐4‐phenyl‐piperazinium (10 m m ), but not a muscarinic agonist pilocarpine (10 m m ), also elicited a biphasic Ca 2+ signal. Even though ACh release from motor nerve endings was blocked by botulinum toxin (5 μg, bolus i.p. before isolation of the tissue), the generation of both a fast and slow Ca 2+ component caused by ACh application was observed. These results strongly suggest that ACh locally applied onto the endplate region of skeletal muscle induces a slow Ca 2+ signal reflecting Ca 2+ entry through a postsynaptic nicotinic AChR, which has a low sensitivity to transmitter ACh.British Journal of Pharmacology (1998) 123 , 1418–1424; doi: 10.1038/sj.bjp.0701725

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom